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Abstract Unplanned general surgery represents a major workload and requires comprehensive evaluation with
appropriate outcomes. This study aimed to summarize current reporting of patient-reported outcomes (PROs) in
randomized clinical trials (RCTs) in unplanned general surgery. A systematic review identified RCTs reporting PROs
in the commonest six areas of unplanned general surgery. Details of the PRO measures were examined using the
CONSORT extension for PRO reporting in RCTs. Extracted information about each PRO domain included the
reporting of baseline PROs, rationale for PRO selection and whether PRO findings were used in conjunction with
clinical outcomes to inform treatment recommendations. The internal validity of included studies was assessed using
the Cochrane risk of bias tool. 12,519 abstracts were screened and 20 RCTs containing data from 2037 patients
included. Included studies used 14 separate PRO measures covering 35 different health domains. A visual analogue
assessment of pain was most frequently reported (n = 13). Reporting of baseline PRO data was uncommon (11/35
PRO domains). The rationale for PRO data collection and a PRO-specific hypothesis were provided for 9 (25.7 %)
and 5 (14.3 %) domains, respectively. Seventeen RCTs (85.0 %) used the PRO data alongside clinical outcomes to
inform treatment recommendations. Of the 116 risk of bias assessments, 77 (66.0 %) were judged as high or unclear.
There is a lack of well designed, and conducted RCTs in unplanned general surgery that include PROs. Future work
to define relevant PROs and methods for optimal assessment are needed to inform health care decision-making.
Introduction
Unplanned admissions to hospital with surgical problems
such as appendicitis, abdominal wall hernia, and bowel
obstruction represent a major volume of morbidity,
healthcare expenditure and work for general surgeons [1–
8]. In the UK, the National Emergency Laparotomy Audit
is examining the processes and outcomes for patients
undergoing emergency laparotomy. This represents
important progress in improving standards of unplanned
general surgical care; however, the audit and other studies
have focused on clinical outcomes, and less is known about
how unplanned general surgical problems impact on
patient-reported outcomes. Understanding patients’ views
and experiences of unplanned surgery are crucial in
enabling interventions to be fully evaluated and ultimately,
improving standards of care [9].
Patient-reported outcomes (PROs) may include assess-
ment of any aspect of health, provided it comes from
patients themselves. The most commonly used measures
to assess PROs are health-related quality of life
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questionnaires, which must be valid and reliable instru-
ments in order to provide accurate measurements [10]. The
recently published PRO CONSORT extension makes rec-
ommendations to improve the way that data from these
questionnaires are reported in RCTs. Improved reporting
should facilitate robust interpretation of RCT results and,
therefore, directly improve patient care [11]. Currently,
little is known about PROs in unplanned general surgery,
and whether standards of reporting are being met. It is
possible that assessment of PROs in this setting is chal-
lenging because patients are often unwell, which may
affect their ability to complete questionnaires before and
after surgery. The aim of this study was to summarize
current evidence regarding the collection of PRO data in
RCTs of unplanned general surgery and to use this infor-
mation to inform the design of future studies in this area.
Materials and methods
A systematic review identified randomized controlled trials
(RCTs) incorporating an assessment of PROs following
unplanned surgery for conditions treated by general sur-
geons. Selected studies focused on RCTs because they
provide high quality evidence and are expected to report
outcomes of importance to patients in addition to clinical
data. Hospital Episode Statistics [12] were used to identify
the most common unplanned operations undertaken by
general surgeons. These were appendectomy, bowel pro-
cedures (e.g. resection/repair/decompression), cholecys-
tectomy, gastroduodenal procedures (e.g. repair of
perforated peptic ulcer), drainage of perianal abscess and
repair of abdominal or groyne hernia. From these, the
corresponding disease areas were extrapolated: appendici-
tis; bowel emergencies (e.g. obstruction, inflammation or
perforation); gastroduodenal emergencies (e.g. peptic
ulcer); acute gallbladder disease; perianal abscess; and
incarceration, obstruction or strangulation of abdominal or
groyne hernia.
Search strategy
The OVID SP version of MEDLINE, Cochrane Controlled
Trials Register, Embase, PsychInfo and CINAHL data-
bases were searched using keywords and MeSH terms
relating to the anatomical location, clinical diagnosis and
treatment of each of the six disease areas listed above,
which were combined using the ‘OR’ operator. These were
combined with standard search strategies for RCTs and
PROs, using the ‘AND’ operator (Appendix 1). Searches
were limited to human studies published in English
between 2007 and 2012 so as to reflect current practice.
Duplicate records were removed and the titles and abstracts
of citations are screened for eligibility by one researcher
(D.S or P.M), using pre-determined selection criteria.
Inclusion of papers
RCTs reporting the results of PROs used to assess the
diagnosis or treatment of conditions within the six disease
areas described above were included. This encompassed
both validated and unvalidated PRO measures (PROMs),
whether as primary or secondary outcomes or part of a
composite endpoint. A PRO was defined as a measure
assessing physical, social or emotional aspects of health
reported by the patients themselves [10]. Trials with a
surgical intervention in at least one group were included,
and surgical interventions were defined as ‘‘those which
involve physically changing body tissues and organs
through manual operation such as cutting, abrading,
suturing or the use of lasers’’ [13]. Studies of elective
surgery were excluded. Independent data extraction from
full text articles meeting the inclusion criteria was per-
formed by at least two authors (D.J.S, P.M or N.B). Where
necessary, discrepancies were resolved by discussion with
J.M.B.
Data extraction
General study information
Details regarding the number of participants, centres and
their broad geographical location were extracted. Reporting
of the nature of the surgical intervention or diagnostic tool
under evaluation, acquirement of ethical approval and the
participant inclusion or exclusion criteria were also asses-
sed. Each RCT was evaluated to assess whether PRO data
were reported in a secondary supplementary paper to a
prior main clinical trial report, or whether the PRO and
clinical data were published together.
Patient-reported outcome assessment
The number and type of PRO measures (questionnaires)
and domains (separate components of health) measured in
each trial were summarized. Reporting standards were
evaluated for each individual PRO domain using the PRO-
specific extension to the Consolidated Standards of
Reporting Trials (CONSORT) Checklist [11]. This tool
provides recommendations for the reporting of PROs
within RCTs, encompassing five main areas: (i) identifica-
tion of PROs as primary or secondary outcomes in the
abstract, (ii) provision of a PRO-specific hypothesis and
relevant domains, (iii) evidence or citation of PROM
instrument validity and reliability, (iv) a description of
methods used to deal with missing data and
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(v) specification of any relevant PRO-specific limitations
of study findings and generalizability of the results to
clinical practice. Other CONSORT reporting standards
include documentation of the primary endpoint, collection
of baseline data, proportions of patients completing ques-
tionnaires at each specified time point, personnel respon-
sible for PRO data collection, physical methods of data
collection and whether PROs were reported alongside
clinical outcomes.
To assess logistical aspects of PRO data collection in the
unplanned setting, reporting of where and when the PRO
consent was obtained from trial participants was recorded,
as well as the total number of assessments performed and
their time points.
Assessment of the risk of bias of included studies
The Cochrane risk of bias tool [14] was used to assess the
methodological quality of each included RCT. This tool
covers all domains of bias: random sequence generation,
allocation concealment, blinding of participants and per-
sonnel, blinding of outcome assessment, incomplete data
and selective reporting. A judgment of high, low or unclear
risk of bias was assigned to each domain by two inde-
pendent researchers (D.S., N.B. Or P.M.). Discrepancies
were assessed by J.S.
Data analysis
Results were tabulated and presented using descriptive
statistics. Evidence synthesis was considered for studies
using similar PROMs in the same clinical area.
Results
Titles and abstracts of 12,519 papers were identified, 76 full
papers obtained and 20 articles included (Fig. 1) [15–34].
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Study design and participants
The 20RCTs (ofwhich halfwere single centre) included data
from2037 patients. Sixteen studies included adults (ofwhich
seven also included children), whilst three did not specify the
age group of participants (Table 1). The surgical conditions
under investigation were appendicitis (n = 13), bowel
emergencies (obstruction = 2 and diverticulitis = 1,
diverticulitis and/or obstruction = 1), acute gallbladder
disease (n = 2) and peptic ulcer disease (n = 1). In most
studies, both trial groups evaluated surgical procedures
(n = 19), whereas one study compared surgical and con-
servative management strategies for appendicitis. Eighteen
trials published the clinical and PRO results together in one
paper. One trial published the PRO results in a separate paper
to the clinical outcomes [29] and another carried out a second
PRO-specific follow-up study that was published more than
10 years after the original trial [30].
Patient-reported outcome assessment
A total of 35 PRO domains were measured using 14 dif-
ferent PROMs across the 20 RCTs, with nine RCTs
including more than one PROM (Table 2). The most fre-
quently measured PRO domain was pain, assessed using a
visual analogue scale (n = 12). Of the studies using this
measure, two provided evidence of its validity [32, 34].
Other PROMs used were the EQ-5D (n = 3), the Short
Form-36 (n = 3) and the gastrointestinal quality of life
index (GIQLI, n = 2).
Reporting standards for each individual PRO domain
measured are summarized in Table 3. Rationale for the
collection of PRO data was provided for nine of 35
domains and a PRO-specific hypothesis was stated for five.
Nine of the PRO domains were identified as either primary
or secondary outcomes in the abstract. Evidence of
instrument validity and reliability was provided for seven
PROs. The personnel responsible for collecting PRO data,
and methods of data collection, were reported for 15 and 19
(paper n = 13, telephone n = 1, paper and telephone
n = 1) of the PROs, respectively. Baseline data were col-
lected for 11 PROs but the actual number of patients
completing the PROs at these assessments was never
reported. The mean number of follow-up time points was
2.6 per PRO (range 1–29), and the number of patients
completing PRO data at each of these follow-ups was
reported 13 times from a possible 99 (13.1 %). The only
study providing an explicit statement of the methods used
to deal with missing data undertook statistical imputation
to assess its impact [22]. Eight PROs were accompanied by
a description of the potential limitations of their use and 26
interpreted the PRO data alongside clinical outcomes.
Table 1 Details of included studies
All studies n = 20
Number of participating centres
Single 10
Multiple 6
Not specified 4
Median number of centres if multiple (range) 1 (1–25)
Geographical region of study
Asia 7
Europe 8
Middle East 1
North America 4
Diagnoses under investigation
Appendicitis 13
Biliary colic/acute cholecystitis 2
Large or small bowel emergencies 4
Peptic ulcer 1
Abdominal wall hernia 0
Perianal abscess 0
Types of intervention studied
Open vs. Minimally invasive surgery 10
Surgery at different time points 4
Open vs. Endoscopy and surgery 2
Components of the same surgical procedurea 2
SILSb vs. minimally invasive surgery 1
Surgery vs. conservative management 1
Inclusion/exclusion criteria
Specified 19
Not specified 1
Nature of primary outcomec
Mortality 0
Complications 4
Peri-operative technical outcomes 1
Treatment pathway outcomes 2
Patient-reported outcomes 2
Cost/resources 1
Not specified 10
Study participants
Adults 9
Children 1
Both 7
Not specified 3
Mean number of participants (range)d 120 (37–369)
IRB or ethical approval reported 14
a e.g. comparing two methods of wound closure
b Single-Incision Laparoscopic Surgery
c Primary outcome fitted two categories therefore percentages cal-
culated from denominator of 22
d Not reported in three of the included studies
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No study provided information on the consent process
for completing PROMs. The location of PROM adminis-
tration was reported in five studies: emergency department
(n = 1), patient’s home (n = 1), postal questionnaire
(n = 1), and on the telephone (n = 2).
Risk of bias
Use of the risk of bias tool generated 116 individual
assessments across the 20 trials, with 77 (66.4 %) judged to
be high or unclear (Table 4).
Data analysis
Data from the PROs were not synthesized because of the
heterogeneity of PROMs, conditions and interventions.
Discussion
This systematic review of PRO reporting in RCTs in
unplanned general surgery identified 20 eligible trials.
None of the measures used to assess PROs were specific for
unplanned surgical settings. Just 11 studies reported base-
line data and the proportion of patients completing follow-
up assessments was rarely documented. Overall, the
methodological quality of the included RCTs was judged to
be poor and reporting of PRO data did not conform to
CONSORT standards. The lack of high quality data means
that more research to evaluate PROs in this setting is
needed.
The importance of incorporating patients’ views about
outcome measurement and reporting within RCTs has been
highlighted by recent guidance [9, 35, 36]. PROs are useful
because they avoid the inherent bias that may occur when
assessments are performed by observers. In addition, they
may detect issues of importance to patients that may be
overlooked in routine clinical follow-up. This review
identified a total of 14 unique PROMs which were used 35
times. Few studies used the same measure at similar time
points, making it impossible to synthesize outcomes. Oth-
ers have highlighted these issues and the difficulties of
combining PROMs [37]. One potential solution to the
problem of heterogeneity of outcomes is to develop and use
a core outcome set. A core outcome set is a minimum set of
agreed outcomes to be measured and reported in all trials of
a particular treatment or condition [37]. The Core Outcome
Measures in Effectiveness Trials (COMET) initiative
emphasizes this approach as a way of aiding data synthesis
and reducing reporting bias [38]. Core outcome sets aim to
include outcomes of importance to all stakeholders,
Table 2 Details of PROMs used
All studies n = 20
(%)
Number of PROMs used per study
One 11 (55.0)
Two 6 (30.0)
Three or more 3 (15.0)
PROMs used1
Gastrointestinal quality of life index
(GIQLI)
2 (5.7)
Short Form-36 (SF-36) 3 (8.6)
EQ-5D 3 (8.6)
Other validated PROM 4 (11.4)
Visual analogue scale (pain) 12 (34.3)
Visual analogue scale (cosmesis) 2 (5.7)
Non-validated instrument 9 (25.7)
Consent process for PRO data collection
reported
0 (0)
Location of PROM administration reported 5 (25.0)
1 Calculated from total number of PROMs used in all 20 studies,
n = 35
Table 3 Reporting standards for PRO data [11]
Number of PROs
n = 35 (%)
PROs identified in the abstract as a primary or
secondary outcome
9 (25.7)
Rationale for PRO assessment provided 9 (25.7)
PRO hypothesis stated in background/
objectives
5 (14.3)
PROs used in eligibility/stratification criteria 0 (0)
Evidence of chosen PRO instrument’s validity
and reliability provided
7 (20)
Reporting of the person completing the PRO: 19 (54.3)
Method of data collection
Paper 13 (37.1)
Telephone 1 (2.9)
Electronic 0 (0)
Other 1 (2.9)
Not reported 20 (57.1)
Explicit statement of statistical approaches for
dealing with missing data
1 (2.9)
Baseline data collected 11 (31.4)
Reporting of number of patients completing
PROMs at follow-upa
13 (13.1)
Additional analyses reported, included
distinction between pre-specified and
exploratory
0 (0)
PRO-specific limitations provided 8 (22.6)
PRO data interpreted alongside clinical
outcomes
27 (74.3)
a From 99 follow-up time points
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including patients [39]. Core outcome sets are being
developed in various surgical contexts including esopha-
geal cancer, breast reconstruction, colorectal and obesity
surgery [40]. A core outcome set for unplanned general
surgery may be helpful in addressing the issues outlined
above and improve evidence synthesis across trials.
Methods for including PROs in core outcome sets have
been previously established [37].
Limitations of this review include the application of
several restrictions to the search criteria. First, databases
were only searched between 2007 and 2012. Whilst it is
possible that the methodological quality of trials and
standards of PRO reporting differed in previous years,
evidence supports a general trend of improved reporting
over time [41]. Second, searches were limited to six broad,
but discrete disease sites. This was done because unplanned
surgery publications are not consistently indexed in liter-
ature databases, and there are no validated search strategies
specifically developed for this area. Hospital Episode
Statistics data was therefore used to identify the six most
common diseases presenting as unplanned admissions to
surgical services. It is possible that RCTs involving less
common conditions were inadvertently missed. Third,
included study designs were limited to RCTs only. This
was necessary in order to ensure the review was manage-
able; 12,519 abstracts were identified and this number
would have been larger if a specific RCTs search strategy
had not been applied. Another reason for including only
RCTs was that the review aimed to assess the quality of
reporting of PROs in unplanned surgery. To the authors’
knowledge, the PRO extension to the CONSORT checklist
is currently the only available tool for assessing reporting
standards—and this is designed specifically for RCTs. The
final limitation is that no PROMs specific for unplanned
general surgery were identified, meaning that content
validity for patients with these conditions could not be
established. Further work may need to ascertain whether
existing PROMs are of relevance and importance to such
patients, and explore whether a PRO-specific tool for
unplanned non-trauma general surgery is required.
Patient-reported outcomes have also been evaluated in
other unplanned settings such as intensive care units, trau-
matic brain injury, acute medical admissions, wartime
injuries, and inpatient rapid response teams [42–45]. Many
similar problems were identified including a lack of PROMs
specific to unplanned conditions, failure to collect baseline
Table 4 Risk of bias assessment [14]
Issue
Sequence
generation
Allocation
concealment
Blinding
(participants/
personnel)
Incomplete
outcome data
Blinding of
outcome
assessment
Selective
outcome
reporting
Other
bias
Bertleff [19] Low risk Unclear risk High risk Low risk High risk High risk
Blakely [25] Low risk High risk High risk Low risk High risk Low risk
Cheung [20] Low risk Unclear risk High risk High risk High riska High risk
Clarke [18] Unclear risk Unclear risk Low risk High risk Low risk High risk
Goudar [26] Unclear risk Unclear risk High risk High risk Unclear risk Low risk
Hansson [21] High risk High risk High risk Low risk Unclear risk Low risk
Kaplan [34] High risk High risk Unclear risk Low risk Low risk Low risk
Kargar [28] Low risk Unclear risk High risk Unclear risk High risk High risk
Klarenbeek [33] Low risk Low risk Low risk Low risk Low risk Low risk
Kouhia [24] Unclear risk High risk Unclear risk Low risk Unclear risk Unclear risk
Macafee [22] Low risk Low risk High risk Low risk High risk Low risk Low risk
Malik [15] Unclear risk High risk Unclear risk Unclear risk Unclear risk Unclear risk
Alam Jan [27] Unclear risk High risk High risk High risk High risk Low risk
Ricca [16] Unclear risk Unclear risk Unclear risk Unclear risk Low risk Unclear risk Low risk
Schurman [29]* * * * * * * *
Suresh [31] Low risk High risk Unclear risk Unclear risk Unclear risk Unclear risk
van der Wal [30] Low risk Unclear risk Unclear risk Unclear risk Unclear risk High risk
van Hooft [17] Low risk Low risk High risk Low risk Unclear risk Low risk
Yadav [23] Unclear risk High risk Unclear risk Unclear risk Unclear risk Unclear risk
Yuen Bun Teoh [32] Low risk Unclear risk Unclear risk Unclear risk Low risk Low risk
* Pilot RCT—not appropriate to assess RoB
a Low risk for mortality and high risk for all other outcomes
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data and heterogeneity in follow-up time points. The relative
dearth of high quality studies assessing PROs in all these
acute settings may reflect logistical difficulties and the
resource intensive nature of collecting such data in this
environment. These problems may help to explain the poor
reporting standards amongst published RCTs, which makes
meaningful interpretation of PRO data difficult. The paucity
of high quality RCTs identified in this review make it diffi-
cult to reliably use PRO data when evaluating the interven-
tions in these studies, meaning more research is needed.
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Appendix 1
Search strategy
Patient-reported outcomes
1. ‘‘Quality of Life’’/.
2. Quality of life.tw.
3. Qol.tw.
4. Hrql.tw.
5. Hrqol.tw.
6. ‘‘Outcome Assessment (Health Care)’’/
7. Patient-reported outcome.tw.
8. Patient-reported outcome.tw.
9. Patient-reported outcome measure.tw.
10. Patient-reported outcome measure.tw.
11. Health Status/
12. Health status.tw.
13. PRO
14. PROM
15. Pain/
16. Physical function.tw.
17. Fatigue/
18. Well-being.tw.
19. Well-being.tw.
20. Health surveys/
21. Treatment outcome/
22. Euroqol.tw.
23. EQ-5D.tw.
24. EQ-3D.tw.
25. Gastrointestinal quality of life index.tw.
26. GIQLI.tw.
27. SF-36.tw.
28. Or/1-27
Randomized trials
1. Randomized Controlled Trials as Topic/
2. Randomized controlled trial/
3. Random Allocation/
4. Double-Blind Method/
5. Single-Blind Method/
6. Clinical trial/
7. Clinical trial, phase i.pt
8. Clinical trial, phase ii.pt
9. Clinical trial, phase iii.pt
10. Clinical trial, phase iv.pt
11. Controlled clinical trial.pt
12. Randomized controlled trial.pt
13. Multicentre study.pt
14. Clinical trial.pt
15. Exp Clinical Trials as topic/
16. Or/1-15
17. (clinical adj trial$)
18. ((singl$ or doubl$ or treb$ or tripl$) adj (blind$3 or
mask$3))
19. PLACEBOS/
20. Placebo$.tw
21. Randomly allocated.tw
22. (allocated adj2 random$).tw
23. Or/17-22
24. 16 or 23
25. Case report.tw
26. Letter/
27. Historical article/
28. Or/25-27
29. 24 not 28
Abscess
1. Anal.tw
2. Anus.tw
3. In-ano.tw
4. Perianal.tw
5. Or/1-4
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6. Abscess/
7. Fistul$
8. Drain$.tw
9. Pus.tw
10. Suppuration/
11. Or/6-10
12. 5 and 11
Appendicitis
1. Appendix/
2. Appendix.tw
3. Appendectomy/
4. Appendicectomy.tw
5. Appendicitis/
6. Appendicitis.tw
7. Or/1-6
8. 7 NEAR/10 perforat*
9. 7 NEAR/10 ruptured
10. Or/1-9
Gallbladder
1. Cholecystolithiasis/
2. Cholecystitis/
3. Cholelithiasis/
4. Pancreatitis/
5. Pancreatitis.tw
6. Biliary colic.tw
7. Empyema.tw
8. Cholecystectomy/
9. Cholecystostomy/
10. Choledochostomy/
11. Or/1-10
Gastric/duodenal
1. 1.Peptic Ulcer/
2. 2.Gastrointestinal H*morrhage/
3. 3.Peptic Ulcer Perforation/
4. 4.Stomach Ulcer/
5. 5.Peptic.tw
6. Gastric.tw
7. Duodenal.tw
8. Stomach.tw
9. Or/5-8
10. Ulcer.tw
11. 9 and 10
12. Or/1-4 or 11
13. 12 NEAR/10 perforation
14. 12 NEAR/10 rupture
15. 12 NEAR/10 haemorrhage
16. 12 NEAR/10 haemorrhage
17. 12 NEAR/10 bleeding
18. Or/13-17 or 12
Hernia
1. Hernia, Abdominal/
2. Hernia, Obturator/
3. Inguinal.tw
4. Femoral.tw
5. Ventral.tw
6. Obturator.tw
7. Umbilical.tw
8. Or/3-7
9. Herni$.tw
10. 8 and 9
11. Or/1-2 or 10
12. 11 NEAR/10 perforation
13. 11 NEAR/10 rupture
14. 11 NEAR/10 obstruction
15. Or/12-14 or 11
16. Herniorrhaphy/
17. Herniorrhaphy.tw
18. Hernia surgery.tw
19. (laparoscop$ adj25 herni$).tw
20. (open adj10 herni$).tw
21. (darn adj10 herni$).tw
22. (mesh adj10 hern$).tw
23. (traditional adj10 herni$).tw
24. (plug adj10 herni$).tw
25. (lichtenstein adj10 herni$).tw
26. Or/16-25
27. 15 and 26
Large/small bowel
1. Divertic$.tw
2. Diverticulum, Colon/
3. Intestinal Obstruction/
4. Intestinal Perforation/
5. Colonic Diseases/
6. Cecal Diseases/
7. Tissue adhesions/
8. Or/1-7
9. 8 NEAR/10 obstruction.tw
10. 8 NEAR/10 perforation.tw
11. 8 NEAR/10 peritonitis.tw
12. 8 NEAR/10 bleeding.tw
13. 8 NEAR/10 haemorrhage.tw
14. 8 NEAR/10 haemorrhage.tw
15. Hartman$.tw
16. Surgical Procedures, Operative/
274 World J Surg (2016) 40:267–276
123
17. Laparoscopy/
18. Resect$.tw.
19. Operat$.tw.
20. Surg$.tw.
21. Laparo$.tw
22. Or/9-21
23. 8 and 22
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